Hypersensitivity reactions to taxanes: a comprehensive and systematic review of the efficacy and safety of desensitization
RV Villarreal-González, S González-Díaz… - Clinical Reviews in …, 2023 - Springer
Taxanes in the treatment of cancer are associated with a significant incidence of
hypersensitivity reactions, which may preclude their use in patients in need of first line …
hypersensitivity reactions, which may preclude their use in patients in need of first line …
Immune Reactions in Major Types of Oncological Treatment
P Kozubek, J Wołoszczak, K Gomułka - International Journal of Molecular …, 2023 - mdpi.com
In recent years, there has been a noticeable development in oncological treatment,
including chemotherapy and biological treatment. Despite their significant effectiveness …
including chemotherapy and biological treatment. Despite their significant effectiveness …
Rapid drug desensitization to taxanes: a descriptive study from Turkey
S Yeşilkaya, K Aksu, GT Vural Solak… - Journal of Oncology …, 2023 - journals.sagepub.com
Aim To present the characteristics of drug hypersensitivity reactions (DHRs) among taxane
recipients with non-small cell lung carcinoma (NSCLC), and to describe the results of rapid …
recipients with non-small cell lung carcinoma (NSCLC), and to describe the results of rapid …
Oxaliplatin-associated shock in stage III colorectal cancer patients: real-world evidence in Taiwan
LY Wang, HH Hsieh, SC Chu… - … Advances in Drug …, 2024 - journals.sagepub.com
Background: Oxaliplatin-associated shock (referred to as shock) is a rare but life-threatening
adverse event. Objectives: This pioneering cohort study aimed to quantitatively investigate …
adverse event. Objectives: This pioneering cohort study aimed to quantitatively investigate …
[HTML][HTML] Successful nedaplatin desensitization therapy in a patient with platinum-sensitive recurrent ovarian cancer: A case report and literature review
T Kokabu, K Aoyama, Y Tarumi, H Kataoka… - Gynecologic Oncology …, 2022 - Elsevier
Desensitization protocols of platinum-based agents are recommended for patients with a
history of hypersensitivity reaction (HSR). Herein, we report the first case of a successful …
history of hypersensitivity reaction (HSR). Herein, we report the first case of a successful …
Allergy testing for Cremophor in a patient with cervical cancer with infusion reactions to paclitaxel and docetaxel
K Nakanishi, S Okazaki, G Ichikawa… - BMJ Case Reports …, 2022 - casereports.bmj.com
A woman in her 30s with cervical cancer underwent postoperative chemotherapy and
showed allergic reactions to multiple taxanes. As the patient had infusion reactions to both …
showed allergic reactions to multiple taxanes. As the patient had infusion reactions to both …